DE:DPM Stock Latest News
Company AnnouncementsSumitomo Pharma’s Revenue Climbs but Profit Drops as Costs and R&D Rise4d ago
Company AnnouncementsSumitomo Pharma to Resume Dividends with 15 Yen Year-End Payout4d ago
Company AnnouncementsSumitomo Pharma Outlines Q2 FY2026 Results with Caution on Projections4d ago
Company AnnouncementsSumitomo Pharma Lifts Full-Year Forecast After Strong U.S. Sales Boost First-Half Results4d ago- Pre-EarningsDNPUF Upcoming Earnings Report: What to Expect?6d ago
Company AnnouncementsSumitomo Pharma to Book Extraordinary Income From Retirement Benefit Trust Asset Return2M ago
Company AnnouncementsSumitomo Pharma Rejects Allegations in Gotham City Research Report3M ago
Company AnnouncementsSumitomo Pharma Q1 FY2026 Profit Surges Despite Higher Costs3M ago- Company AnnouncementsSumitomo Pharma Flags Uncertainty in Q1 FY2026 Outlook3M ago
Company AnnouncementsSumitomo Pharma Affirms Independence as Sumitomo Chemical Retains Control4M ago
Company AnnouncementsSumitomo Pharma Cancels Planned Third-Party Share Allotment After Allottee Declines5M ago
- Company AnnouncementsSumitomo Pharma Issues Cautious FY2025 Results Conference Materials5M ago
Company AnnouncementsSumitomo Pharma Ends Major Equity Offering, Withdraws Share Issuance Shelf6M ago
Company AnnouncementsSumitomo Pharma Sets Terms for Over ¥100 Billion Equity Offering6M ago
Company AnnouncementsSumitomo Pharma Refinances Guaranteed Debt With New Bridge Loan6M ago
Company AnnouncementsSumitomo Pharma Launches Major Share Offering to Strengthen Financial Base6M agoCompany AnnouncementsSumitomo Pharma to Book ¥48.3 Billion Dividend as Non-Operating Income With No Group Profit Impact7M ago
Company AnnouncementsSumitomo Pharma Wins Conditional Japan Approval for First iPS Cell-Derived Parkinson’s Therapy8M ago